Zymeworks Inc
Change company Symbol lookup
Select an option...
ZYME Zymeworks Inc
NYC American Strategic Investment Co
MDV Modiv Inc
SBIG springbig Holdings Inc
KBNT Kubient Inc
FGF FG Financial Group Inc
NVNO enVVeno Medical Corp
BROGW Brooge Holdings Equity Warrants Expiring 20 Dec 2024 *W EXP 12/20/2024
IOVA Iovance Biotherapeutics Inc
PUYI Puyi Inc

Health Care : Biotechnology | Small Cap Blend
Company profile

Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its lead product candidate, zanidatamab, is a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Its second product candidate, zanidatamab zovodotin, combines the biparatopic antibody design of zanidatamab with its ZymeLink auristatin antibody-drug conjugate (ADC) technology, comprised of its cytotoxin (cancer cell-killing compound) and cleavable linker. It is also advancing a pipeline of preclinical product candidates and discovery-stage programs in oncology (including immuno-oncology agents) and other therapeutic areas with an emphasis on developing ADC and multi-specific antibody therapeutics (MSAT) candidates. Its pipeline of preclinical product candidates includes two lead programs, ZW191 and ZW17.

Closing Price
Day's Change
-0.17 (-2.02%)
B/A Size
Day's High
Day's Low

10-day average volume:

Upcoming Events

ZYME's fiscal year ends in December
There are no upcoming events for ZYME

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
May 8, 2023Q1 2023 Earnings Release-$0.36-$0.88 to -$0.02-$1.18
March 7, 2023Q4 2022 Earnings Release$4.65$3.88 to $5.50-$0.76
November 8, 2022Q3 2022 Earnings Release-$0.72-$1.15 to -$0.74-$1.17
August 4, 2022Q2 2022 Earnings Release-$0.97-$1.14 to -$0.78-$1.31

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.